Welcome to Paid Research Studies




  • Condition:   Anal Cancer
    Intervention:   Drug: Pembrolizumab
    Sponsors:   Dana-Farber Cancer Institute;   Merck Sharp & Dohme Corp.
    Recruiting

  • Condition:   Anal Cancer
    Interventions:   Behavioral: Home-based human papillomavirus (HPV) DNA screening;   Behavioral: Clinic-based human papillomavirus (HPV) DNA screening
    Sponsors:   Medical College of Wisconsin;   Baylor College of Medicine;   National Cancer Institute (NCI);   The University of Texas Health Science Center, Houston
    Not yet recruiting

  • Condition:   Anal Cancer
    Interventions:   Radiation: 2.15 gray and 1.8 gray. Max. 6 weeks.;   Radiation: 2.15 gray and 1.8 gray. Max. 5 weeks.
    Sponsor:   Vejle Hospital
    Recruiting

  • Condition:   Anal Cancer
    Intervention:   Other: anal cancer
    Sponsor:   Centre Antoine Lacassagne
    Recruiting

  • Condition:   Anal Cancer
    Intervention:  
    Sponsor:   Sahlgrenska University Hospital, Sweden
    Recruiting

  • Condition:   Rectal or Anal Cancer
    Interventions:   Radiation: endorectal brachytherapy;   Drug: concurrent capecitabine or 5-FU;   Behavioral: Questionnaires
    Sponsor:   Memorial Sloan Kettering Cancer Center
    Recruiting

  • Condition:   Anal Cancer
    Interventions:   Drug: MPDL3280A;   Drug: mDCF
    Sponsors:   GERCOR - Multidisciplinary Oncology Cooperative Group;   Roche Pharma AG
    Recruiting

  • Conditions:   Anal Cancer;   Quality of Life;   Chemoradiation
    Interventions:   Other: EORTC QLQ C30;   Other: EORTC QLQ CR29
    Sponsor:   Ludwig-Maximilians - University of Munich
    Recruiting

  • Conditions:   Anal Cancer, Squamous Cell Carcinoma;   Radiation Exposure
    Intervention:   Drug: BMX-001
    Sponsors:   Chi Lin, MD;   BioMimetix JV, LLC;   University of Nebraska
    Recruiting

  • Conditions:   Cancer of Head and Neck;   Cancer of Cervix;   Cancer of Anus
    Intervention:   Drug: DPX-E7 vaccine
    Sponsors:   Dana-Farber Cancer Institute;   Stand Up To Cancer
    Recruiting

  • Condition:   Anal Cancer Squamous Cell
    Intervention:   Dietary Supplement: prebiotics in combination with probiotics
    Sponsor:   AC Camargo Cancer Center
    Recruiting

  • Conditions:   Anal Cancer;   High-grade Squamous Intraepithelial Lesion;   HIV Infection;   Human Papilloma Virus Infection
    Interventions:   Drug: imiquimod;   Drug: fluorouracil;   Device: infrared photocoagulation therapy;   Device: thermal ablation therapy;   Device: laser therapy;   Other: clinical observation;   Other: laboratory biomarker analysis
    Sponsors:   AIDS Malignancy Consortium;   National Cancer Institute (NCI);   The EMMES Corporation;   University of Arkansas;   University of California, San Francisco
    Recruiting

  • Conditions:   Anal Basaloid Carcinoma;   Anal Canal Cloacogenic Carcinoma;   Anal Margin Squamous Cell Carcinoma;   Stage II Anal Canal Cancer AJCC v6 and v7;   Stage IIB Anal Cancer AJCC v8;   Stage III Anal Canal Cancer AJCC v6 and v7;   Stage IIIA Anal Canal Cancer AJCC v6 and v7;   Stage IIIB Anal Canal Cancer AJCC v6 and v7
    Intervention:   Biological: Nivolumab
    Sponsors:   National Cancer Institute (NCI);   Canadian Cancer Trials Group
    Recruiting

  • Conditions:   Vulvar Cancer;   Cervical Cancer;   Vulvar Dysplasia;   Cervical Dysplasia;   Anal Cancer;   Anal Dysplasia;   HPV-Related Anal Squamous Cell Carcinoma
    Interventions:   Procedure: Screening anal Pap smear - No high-resolution anoscopy;   Procedure: Screening anal Pap smear - High-resolution anoscopy
    Sponsor:   Dr. Danielle Vicus
    Not yet recruiting

  • Conditions:   Cervical Adenocarcinoma;   Cervical Adenocarcinoma In Situ;   Cervical Intraepithelial Neoplasia;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cervical Squamous Intraepithelial Neoplasia;   Early Invasive Cervical Adenocarcinoma;   Early Invasive Cervical Squamous Cell Carcinoma;   High Grade Cervical Squamous Intraepithelial Neoplasia;   High Grade Vaginal Intraepithelial Neoplasia;   Low Grade Vaginal Intraepithelial Neoplasia;   Stage I Cervical Cancer AJCC v8;   Stage I Vaginal Cancer AJCC v8;   Stage I Vulvar Cancer AJCC v8;   Stage IA Cervical Cancer AJCC v8;   Stage IA Vaginal Cancer AJCC v8;   Stage IA Vulvar Cancer AJCC v8;   Stage IA1 Cervical Cancer AJCC v8;   Stage IA2 Cervical Cancer AJCC v8;   Stage IB Cervical Cancer AJCC v8;   Stage IB Vaginal Cancer AJCC v8;   Stage IB Vulvar Cancer AJCC v8;   Stage IB1 Cervical Cancer AJCC v8;   Stage IB2 Cervical Cancer AJCC v8;   Stage II Cervical Cancer AJCC v8;   Stage II Vaginal Cancer AJCC v8;   Stage II Vulvar Cancer AJCC v8;   Stage IIA Cervical Cancer AJCC v8;   Stage IIA Vaginal Cancer AJCC v8;   Stage IIA1 Cervical Cancer AJCC v8;   Stage IIA2 Cervical Cancer AJCC v8;   Stage IIB Cervical Cancer AJCC v8;   Stage IIB Vaginal Cancer AJCC v8;   Stage III Cervical Cancer AJCC v8;   Stage III Vaginal Cancer AJCC v8;   Stage III Vulvar Cancer AJCC v8;   Stage IIIA Cervical Cancer AJCC v8;   Stage IIIA Vulvar Cancer AJCC v8;   Stage IIIB Cervical Cancer AJCC v8;   Stage IIIB Vulvar Cancer AJCC v8;   Stage IIIC Vulvar Cancer AJCC v8;   Stage IV Cervical Cancer AJCC v8;   Stage IV Vaginal Cancer AJCC v8;   Stage IV Vulvar Cancer AJCC v8;   Stage IVA Cervical Cancer AJCC v8;   Stage IVA Vaginal Cancer AJCC v8;   Stage IVA Vulvar Cancer AJCC v8;   Stage IVB Cervical Cancer AJCC v8;   Stage IVB Vaginal Cancer AJCC v8;   Stage IVB Vulvar Cancer AJCC v8;   Vaginal Adenocarcinoma;   Vulvar Adenocarcinoma;   Vulvar High Grade Squamous Intraepithelial Lesion;   Vulvar Intraepithelial Neoplasia;   Vulvar Squamous Cell Carcinoma;   Vulvar Squamous Intraepithelial Lesion
    Interventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Cervical Cancer;   Anal Cancer;   Penile Cancer
    Intervention:   Behavioral: Framed HPV vaccination messages
    Sponsor:   University of Maryland
    Not yet recruiting

  • Conditions:   Rectal Cancer;   Anal Canal Cancer
    Interventions:   Procedure: Traditional Closure;   Procedure: "Cross" closure
    Sponsors:   Sixth Affiliated Hospital, Sun Yat-sen University;   First Affiliated Hospital, Sun Yat-Sen University;   First Affiliated Hospital of Jinan University;   The First Affiliated Hospital of Guangzhou Medical University;   Second Affiliated Hospital of Guangzhou Medical University;   Southern Medical University, China;   Guangdong Provincial Hospital of Traditional Chinese Medicine;   Guangzhou First People's Hospital;   The Affiliated Hospital of Guangdong Medical College;   Cancer Institute and Hospital, Chinese Academy of Medical Sciences;   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine;   Meizhou People's Hospital;   Jieyang People's Hospital
    Not yet recruiting

  • Conditions:   Anal Cancer;   Cervical Cancer;   Lung Cancer;   Lymphoma
    Interventions:   Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: polymorphism analysis;   Other: biologic sample preservation procedure;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: medical chart review
    Sponsors:   AIDS Malignancy Consortium;   National Cancer Institute (NCI);   The EMMES Corporation;   AIDS and Cancer Specimen Resource;   University of Arkansas
    Recruiting

  • Conditions:   Anal Dysplasia;   Carcinoma in Situ
    Interventions:   Drug: Gliolan;   Drug: Vitamin D3 cholecalciferol);   Other: Photodynamic Therpay
    Sponsor:   Abramson Cancer Center of the University of Pennsylvania
    Recruiting

  • Conditions:   Anal Canal Squamous Cell Carcinoma;   Stage I Anal Cancer AJCC v8;   Stage II Anal Cancer AJCC v8;   Stage IIA Anal Cancer AJCC v8;   Stage IIB Anal Cancer AJCC v8;   Stage III Anal Cancer AJCC v8;   Stage IIIA Anal Cancer AJCC v8;   Stage IIIB Anal Cancer AJCC v8;   Stage IIIC Anal Cancer AJCC v8
    Interventions:   Drug: Cisplatin;   Drug: Fluorouracil;   Radiation: Linear Energy Transfer-Optimized Intensity Modulated Proton Therapy;   Procedure: Quality-of-Life Assessment;   Other: Questionnaire Administration
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Locally Advanced Anal Canal Cancer
    Interventions:   Drug: 5Fluorouracile and Mitomycin-C;   Radiation: Simultaneously integrated boost of intensity modulated radiation therapy (SIB-IMRT) by tomotherapy
    Sponsors:   Centre Francois Baclesse;   Accuray Incorporated
    Recruiting

  • Conditions:   Human Papilloma Virus;   Cervical Cancer;   Oropharyngeal Cancer;   Anal Cancer;   Vaginal or Penile Cancer
    Intervention:   Drug: M7824
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Human Papillomavirus-Related Carcinoma;   Human Papillomavirus Positive Oropharyngeal Carcinoma;   Human Papillomavirus Positive Cervical Carcinoma;   Human Papillomavirus Positive Anal Carcinoma;   Human Papillomavirus Positive Vulvar Carcinoma;   Human Papillomavirus Positive Penile Carcinoma
    Interventions:   Genetic: HPV Specific T Cells;   Drug: Cytoxan;   Drug: Fludarabine;   Biological: Nivolumab
    Sponsors:   Baylor College of Medicine;   Center for Cell and Gene Therapy, Baylor College of Medicine;   The Methodist Hospital System
    Recruiting

  • Conditions:   Radiation Therapy;   Cancer;   Cancer of Anus;   Cancer of Bladder;   Cancer of Cervix;   Cancer of Colon;   Cancer of Rectum;   Cancer of Esophagus;   Cancer of Gallbladder;   Cancer of Liver;   Cancer of Ovary;   Cancer of Pancreas;   Cancer of Prostate;   Cancer of Kidney and Renal Pelvis;   Cancer of Stomach;   Cancer of Testis;   Cancer of Uterus;   Cancer of Uterus and Cervix;   Cancer of Kidney
    Intervention:  
    Sponsors:   DxTerity Diagnostics;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma;   Breastcancer;   Leukemia;   Melanoma;   Sarcoma;   Unknown Primary Tumor;   Multiple Myeloma;   Ovarian Cancer;   Endometrial Cancer;   Vaginal Cancer
    Intervention:  
    Sponsor:   University of Nebraska
    Recruiting

  • Conditions:   Melanoma;   Breast Carcinoma;   Hepatocellular Carcinoma;   Urothelial Carcinoma;   Squamous Cell Carcinoma of the Head and Neck;   Renal Cell Carcinoma;   Colorectal Carcinoma;   Non-small Cell Lung Carcinoma;   Gastric or Gastroesophageal Junction Adenocarcinoma;   Endometrial Carcinoma;   Mesothelioma;   Neuroendocrine Carcinoma;   Cervical Cancer;   Small Cell Lung Carcinoma;   Squamous Cell Carcinoma of the Anus
    Intervention:   Biological: XmAb20717
    Sponsors:   Xencor, Inc.;   ICON plc
    Recruiting

  • Conditions:   Anal Canal Squamous Cell Carcinoma;   Metastatic Anal Canal Carcinoma;   Stage IV Anal Canal Cancer AJCC v6 and v7
    Interventions:   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Human Papillomavirus-16 Positive;   Human Papillomavirus-18 Positive;   Metastatic Malignant Neoplasm;   Recurrent Anal Canal Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Malignant Neoplasm;   Recurrent Penile Carcinoma;   Recurrent Vaginal Carcinoma;   Recurrent Vulvar Carcinoma;   Refractory Malignant Neoplasm;   Stage IV Anal Cancer AJCC v8;   Stage IV Cervical Cancer AJCC v8;   Stage IV Penile Cancer AJCC v8;   Stage IV Vaginal Cancer AJCC v8;   Stage IV Vulvar Cancer AJCC v8;   Stage IVA Cervical Cancer AJCC v8;   Stage IVA Vaginal Cancer AJCC v8;   Stage IVA Vulvar Cancer AJCC v8;   Stage IVB Cervical Cancer AJCC v8;   Stage IVB Vaginal Cancer AJCC v8;   Stage IVB Vulvar Cancer AJCC v8
    Interventions:   Biological: DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457;   Biological: Durvalumab
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Cancer That is Associated With a Chronic Viral Infection;   p16 Positive SCCHN;   Squamous Cell Carcinoma of the Cervix;   p16 Positive Squamous Cell Carcinoma of the Vagina or Vulva;   p16 Positive Squamous Cell Carcinoma of the Penis;   p16 Positive Squamous Cell Carcinoma of the Anus or Anal Canal;   EBER Positive NPC;   EBER Positive Hodgkins and Non-hodgkins Lymphona
    Interventions:   Drug: Valproic Acid;   Biological: Avelumab
    Sponsors:   AHS Cancer Control Alberta;   EMD Serono
    Recruiting

  • Conditions:   Advanced Malignant Solid Neoplasm;   Anal Carcinoma;   HIV Infection;   Kaposi Sarcoma;   Lung Carcinoma;   Metastatic Malignant Solid Neoplasm;   Recurrent Classic Hodgkin Lymphoma;   Refractory Classic Hodgkin Lymphoma;   Unresectable Solid Neoplasm
    Interventions:   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Squamous Cell Carcinoma of the Head and Neck;   Melanoma;   Non Small Cell Lung Cancer;   Urothelial Carcinoma;   Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma;   Squamous Cell Carcinoma of the Anus;   Squamous Cell Carcinoma of the Cervix;   Squamous Cell Carcinoma of the Skin;   Renal Cell Carcinoma;   Hodgkin Lymphoma;   Diffuse Large B Cell Lymphoma;   Mismatch Repair Deficient or MSI-High Solid Tumors
    Intervention:   Drug: SL-279252
    Sponsor:   Shattuck Labs, Inc.
    Recruiting

  • Conditions:   Breast Carcinoma;   Head and Neck Cancer;   Melanoma (Skin);   Squamous Cell Carcinoma, Skin;   Cervix Cancer;   Endometrium Cancer;   Ovary Cancer;   Vulva Cancer;   Anus Cancer;   Rectum Cancer
    Interventions:   Drug: Indocyanine green;   Drug: Technetium99;   Device: Optonuclear probe
    Sponsor:   Institut de Cancérologie de Lorraine
    Recruiting

  • Conditions:   Anal Squamous Cell Carcinoma;   HIV Infection;   Stage 0 Anal Canal Cancer;   Stage I Anal Canal Cancer
    Intervention:   Procedure: Therapeutic Conventional Surgery
    Sponsors:   AIDS Malignancy Consortium;   National Cancer Institute (NCI);   The EMMES Corporation
    Recruiting

  • Conditions:   Cancer, All Types;   Cancer of Liver;   Cancer of Stomach;   Cancer of Head and Neck;   Cancer of Rectum;   Cancer of Kidney;   Cancer of Esophagus;   Cancer of Colon;   Cancer Skin;   Cancer of Cervix;   Cancer, Metastatic;   Cancer of Larynx;   Cancer of Neck;   Cancer of Lung;   Cancer of Brain and Nervous System;   Cancer of Vulva, Disseminated;   Cancer of Pancreas;   Sarcoma;   GIST;   Small-cell Lung Cancer;   Adenocarcinoma Lung;   Cancer of Prostate;   Cancer, Advanced;   Adrenal Cancer;   Testicular Cancer;   Uterine Cancer;   Bronchoalveolar Cell Lung Cancer;   Cancer Unknown Primary;   Glioblastoma Multiforme;   Oligodendroglioma;   Breast Cancer;   Renal Cell Carcinoma;   Hepatocellular Carcinoma;   Cholangiocarcinoma;   Squamous Cell Carcinoma;   Transitional Cell Carcinoma;   Cancer, Other;   Cancer, Anal;   Melanoma;   Cancer, Bile Duct;   Cancer, Bladder;   Cancer Cords Vocal;   Cancers Cell Neuroendocrine;   Cancer Differentiated Poorly;   Cancer, Anaplastic Thyroid
    Intervention:  
    Sponsors:   SpeciCare;   Dana-Farber Cancer Institute;   Kalispell Regional Medical Center;   Georgia Institute of Technology;   Ontario Institute for Cancer Research;   SEngine Precision Medicine;   Helomics
    Recruiting

  • Condition:   Advanced Cancer
    Intervention:   Biological: pembrolizumab
    Sponsor:   Merck Sharp & Dohme Corp.
    Recruiting

  • Condition:   Rectal Cancer
    Interventions:   Procedure: TaTME;   Procedure: TME
    Sponsor:   Case Comprehensive Cancer Center
    Recruiting

  • Conditions:   High Grade Anal Canal Squamous Intraepithelial Neoplasia;   Vulvar High Grade Squamous Intraepithelial Lesion
    Interventions:   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Questionnaire Administration;   Biological: Recombinant Human Papillomavirus Nonavalent Vaccine
    Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   HPV-Related Anal Intraepithelial Neoplasia;   AIN2/3;   Artesunate;   Alternative Treatment;   Anal Dysplasia;   Precancerous Conditions;   Human Papilloma Virus
    Intervention:   Drug: Artesunate Suppositories
    Sponsors:   Johns Hopkins University;   Frantz Medical Group
    Recruiting

  • Condition:   Human Immunodeficiency Virus
    Intervention:   Diagnostic Test: HPV genotyping
    Sponsors:   Universitaire Ziekenhuizen Leuven;   Belgian Scientific Institute of Public Health
    Recruiting

  • Conditions:   Liver Metastases;   Colorectal Cancer;   Anal Canal Cancer;   Gastrointestinal Neuroendocrine Tumors
    Intervention:   Radiation: SBRT
    Sponsors:   University of Sao Paulo;   Instituto do Cancer do Estado de São Paulo
    Recruiting